Skip to search formSkip to main contentSkip to account menu

Electrocorticogram

Known as: Intracranial EEG, Intracranial Electroencephalographies, Electrocorticographies 
The use of electrodes placed directly on the exposed brain surface to record the electrical activity of the cerebral cortex.
National Institutes of Health

Related topics

Related topics

6 relations
Electroencephalographyaspects of radiation effectsnursing therapystandards characteristics

Narrower (2)

Extraoperative ElectrocorticographyIntraoperative Electrocorticography

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Activity of cediranib (AZD2171) in patients (pts) with previously untreated metastatic renal cell cancer (RCC). A phase II trial of the PMH Consortium
5047 Background: Cediranib (AZD2171) is an oral highly potent, selective pan-VEGFR tyrosine kinase inhibitor expected to show… 
2008
2008
A phase II study: Combination of sorafenib with docetaxel and cisplatin in the treatment of metastatic or advanced unresectable gastric and gastroesophageal junction (GEJ) adenocarcinoma (ECOG 5203)
4535 Background: Adenocarcinoma of the stomach and gastroesophageal junction (GEJ) is a highly virulent disease and remains a… 
2007
2007
Cyclophosphamide and fludarabine (CF) in advanced indolent lymphoma: Results from the ECOG/CALGB intergroup E1496 trial
8004 Background: To determine optimal induction and the role of maintenance, the E1496 study randomized patients (pts) to… 
2007
2007
Feature combination for classifying single-trial ECoG during motor imagery of different sessions
Progress in Natural Science Publication details, including instructions for authors and subscription information: http://www… 
2005
2005
Results of 3rd line therapy on N9841: a randomized phase III trial of oxaliplatin/5-fluorouracil (5FU)/leucovorin (FOLFOX4) versus irinotecan (CPT-11) in patients (pts) with advanced colorectal…
3519 Background: The primary goal of the Intergroup trial N9841 was to determine whether overall survival (OS) of pts treated… 
2005
2005
Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma
PurposeTo evaluate the efficacy and toxicity profile of the combination of docetaxel and prolonged gemcitabine infusion in front… 
2004
2004
Phase I and pharmacokinetic study of the farnesyltransferase inhibitor R115777 in combination with irinotecan in patients with advanced cancer
PurposeR115777 is a selective, nonpeptidomimetic inhibitor of farnesyltransferase (FTase), an enzyme responsible for the post… 
1997
1997
Activity of gemcitabine in the treatment of patients with non-small cell lung cancer: a multicenter phase II study
Gemcitabine is a novel nucleoside analog with unique activity against a wide range of solid tumors. We initiated a multicenter… 
1992
1992
Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology Group.
These ECOG trials have demonstrated that progressive increments in the intensity of post-remission therapy result in improving… 
1987
1987
Phase II study of oral 4-demethoxydaunorubicin in previously treated (except anthracyclines) metastatic breast cancer patients.
Forty-eight patients with metastatic breast cancer previously treated with cytostatics (except anthracyclines) underwent peroral…